Carfilzomib (K) vs low-dose corticosteroids and optional cyclophosphamide (cy) in patients (pts) with relapsed and refractory multiple myeloma (RRMM): results from a phase 3 study (FOCUS)

Authors: H Ludwig Masszi, T Petrucci, MT Palumbo, A Rosiñol, L Nagler, A Yong, KL Minarik, J Dimopoulos, MA Maisnar, V others
Publication date: 1 January 2014
Publisher

Abstract

Abstract is not available.

Similar works

Full text

thumbnail-image

Available Versions

Pergamos : Unified Institutional Repository / Digital Library Platform of the National and Kapodistrian University of Athens

redirect

oai

oai:lib.uoa.gr:uoadl:2953940

Last time updated on 10/02/2023